Please contact your health insurance company to confirm provider participation. For billing and insurance questions, please call our Billing Department at 210-358-3260.
About
I joined the faculty of UT Health San Antonio in July 2013 as an assistant clinical professor in the division of gynecologic oncology.
My expertise includes the diagnosis, treatment and research of cervical, endometrial, ovarian and vulvar cancers.
I also have advanced surgical training in robotic and laparoscopic procedures, radical pelvic and reconstructive surgery, surgery for the diagnosis and treatment of gynecologic cancers and complicated benign gynecologic conditions.
I completed my gynecologic oncology fellowship at The Ohio State University Medical Center after a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania, where I was elected administrative chief resident.
I have authored or co-authored more than 35 papers published in peer reviewed journals and look forward to advancing my research while caring for the unique patient population of central and south Texas.
Articles & Publications
Journal Articles
Adams SF, Grimm AJ, Chiang CL, Mookerjee A, Flies D, Jean S, McCann GA, Michaux J, Pak H, Huber F, Neal C, Dangaj D, Bassani-Sternberg M, Rusakiewicz S, Facciabene A, Coukos G, Gimotty PA, Kandalaft LE. Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes. J Immunother Cancer. 2020 Aug;8(2):e000875. doi: 10.1136/jitc-2020-000875. PMID: 32817208; PMCID: PMC7430560.
Backes FJ, Rosen M, Liang M, McCann GA, Clements A, Cohn DE, OʼMalley DM, Salani R, Fowler JM . Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative Complications. Int J Gynecol Cancer. 2015 Sep;25(7):1271-6. doi: 0.1097/IGC.0000000000000480. PubMed PMID: 26017249.
McCann GA, Cohn DE, Jewell EL, Havrilesky LJ . Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis. Gynecol Oncol. 2015 Feb;136(2):300-4. doi: 10.1016/j.ygyno.2014.11.079. Epub 2014 Dec 2. PubMed PMID: 25478927.
McCann GA, Naidu S, Rath KS, Bid HK, Tierney BJ, Suarez A, Varadharaj S, Zhang J, Hideg K, Houghton P, Kuppusamy P, Cohn DE, Selvendiran K. Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor. Oncoscience. 2014 Mar 31;1(3):216-28. eCollection 2014. PubMed PMID: 25594014; PubMed Central PMCID: PMC4278289.
